4 Analysts Have This to Say About ALX Oncology Holdings
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on ALX Oncology Holdings (NASDAQ:ALXO) stock. The analysts have an average price target of $16.0 versus the current price of ALX Oncology Holdings at $5.05, implying upside. This current average has decreased by 52.0% from the previous average price target of $33.33.
August 11, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have a bullish outlook on ALX Oncology Holdings (NASDAQ:ALXO) with an average price target of $16.0, implying upside from the current price of $5.05. However, the average price target has decreased by 52.0% from the previous target of $33.33.
The bullish outlook from analysts suggests a potential upside for ALX Oncology Holdings. However, the decrease in the average price target could indicate a less optimistic view compared to previous assessments. This could impact the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100